News and Trends 8 Jan 2016Epigenetics Baby of Proteros is Signing Up with Top US Neurology Specialists Founded in just 2013 by German Proteros and the US Atlas Ventures, Rodin Therapeutics is working epigenetics into discovery of… January 8, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jan 2016Growing Mini-Brains in Labs to Better Understand Neurological Disease Mini brains, about 3-4 mm are a breakthrough in Neurology which will enable researchers to study the development of neurological… January 6, 2016 - 2 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 22 Dec 2015Dutch Organ-on-Chip Biotech Hauls in €1.5M Funding from Pharma Syndicate in Project Against Animal Testing Mimetas from Leiden (NL) has now been financed to develop an Organ-on-Chip (tissue model) to specifically test Neurotoxicity, as a… December 22, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2015Latest Small Molecule against Alzheimer’s Disease Success in Phase I Trials Probiodrug's phase I tolerability and efficacy trial for Alzheimer's didn't quite go as planned, although results are in and it… December 15, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 7 Dec 2015Hydra’s Immortality is not Myth: Polyps Genetically Reprogram Skin Cells into Neurons Relatives of the Jellyfish, researchers at the University of Geneva (Switzerland) have now proven the regenerative abilities of Hydra involved… December 7, 2015 - 3 minutesmins - By Lourdes Riquelme Share WhatsApp Twitter Linkedin Email
News and Trends 4 Dec 2015Black Friday Ruin as TWO Biotechs Fail in Phase III Trials A shocking Black Friday for these two Biotechs: Both CytoTools (Germany) and MedDay (France) phase III trials in chronic disease… December 4, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 30 Nov 2015Heptares’ G-Protein StaR Platform has now Hooked Pfizer in a Billion Euro Deal Heptares Therapeutics from the UK has landed Pfizer in a huge potential $1.9Bn deal for their G-protein receptor platform. Heptares… November 30, 2015 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 26 Nov 2015The UK-Israeli €378M Small-Molecule Offensive Against Migraines The Israeli TEVA and UK Heptares Therapeutics (now owned by Japanese Sosei) have partnered up on novel drug therapies targeting… November 26, 2015 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 24 Nov 20152015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease? Since both Alzheimer's Disease and Parkinson's combined affect up to 50 million people worldwide, it is no wonder this new… November 24, 2015 - 9 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 17 Nov 2015Epigenetics Drug Discovery has a New Champion! Last week at BIO-Europe 2015 in Munich, I had the opportunity to meet Torsten Hoffmann, CSO of Proteros who told… November 17, 2015 - 4 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 16 Nov 2015Swissmedic Approves Zambon and Newron Therapy against Parkinson’s Italian Pharma Newron and its partner Zambon (from Milan) have been granted a license by Swissmedic (the regulatory agency in Switzerland)… November 16, 2015 - 2 minutesmins - By Julie Lellouche Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2015Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue! The fight against Alzheimer's with the World Health Organization and the G8 Dementia Summit rallies a collective of biotech industry… October 26, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2015Neurodegenerative Disease in the UK: Takeda, NIHR & UCL Research Collaboration Takeda Cambridge (the UK subsidiary of global biotech Takeda Pharmaceuticals) will now collaborate with University College London's Institute for Neurology… October 15, 2015 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2015Spanish connection: VC leads Biotech series A Fund to cure Rare Neurodegenerative Disease Minoryx Therapeutics is a Barcelona based Rare-disease specialist who has a panel of orphan-drug experts for their discovery program. Now… October 15, 2015 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 14 Oct 2015High-Risk Infant Cancer: Nature publishes on a New and Reliable Biomarker from Cologne New Oncology from Cologne (Germany) is a biotech which today published a paper in Nature on tumor-profile recognition of cancer of… October 14, 2015 - 4 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 9 Oct 2015TauRX, the leading Alzheimer-focused Biotech, earns funding after Phase II breakthrough The Tau protein has already been implicated in the onset of Alzheimer's, with many biotechs on the hunt for a… October 9, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 1 Oct 2015Asceneuron’s latest stab at the Alzheimer’s challenge with Sofinnova Paris based Sofinnova continues to invest in the Alzheimer's fight, with a €27.5M pot given to Swiss Asceneuron (originally a… October 1, 2015 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 28 Sep 2015New Smart Collaboration of Nestlé and AC Immune Against Alzheimer’s disease Nestlé Institute of Health Sciences (NIHS) is teaming up with the Swiss AC Immune to develop a new minimally invasive… September 28, 2015 - 2 minutesmins - By Julie Lellouche Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2015UniQure’s cure for rare Lysosomal disease ready for phase III trial UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial targeting a rare Lysosomal disease.… September 22, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jul 2015AC Immune receives Milestone Payment for Alzheimer Antibody AC Immune received a first milestone payment from Roche’s subsidiary Genentech. The latter picked up a potential Alzheimer’s drug worth… July 17, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email